KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Labcorp Holdings (LH) EBIT Margin (2016 - 2025)

Labcorp Holdings (LH) has disclosed EBIT Margin for 17 consecutive years, with 7.61% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 111.0% to 7.61% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 9.92% through Dec 2025, up 157.0% year-over-year, with the annual reading at 9.92% for FY2025, 157.0% up from the prior year.
  • EBIT Margin hit 7.61% in Q4 2025 for Labcorp Holdings, down from 11.13% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 48.51% in Q4 2021 to a low of 4.05% in Q4 2023.
  • Historically, EBIT Margin has averaged 12.72% across 5 years, with a median of 10.49% in 2023.
  • Biggest five-year swings in EBIT Margin: skyrocketed 3224bps in 2021 and later tumbled -4754bps in 2022.
  • Year by year, EBIT Margin stood at 48.51% in 2021, then crashed by -98bps to 0.97% in 2022, then tumbled by -516bps to 4.05% in 2023, then surged by 261bps to 6.5% in 2024, then increased by 17bps to 7.61% in 2025.
  • Business Quant data shows EBIT Margin for LH at 7.61% in Q4 2025, 11.13% in Q3 2025, and 11.18% in Q2 2025.